insights_auto
Outlook: 22.2% bullish·16.7% bearish
Go to analysischevron_right
A1RG34:BVMF
Argenx Se Bdr
165,44 R$
0,00%
(0,00) 1D
9 հոկ, 16:56:00 GMT-3 · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Open
165,44 R$
High
165,44 R$
Low
165,44 R$
Mkt. cap
50,06 մլրդ
Avg. vol.
59,00
Volume
8,00
52-wk high
213,15 R$
52-wk low
143,22 R$
Shares outstanding
62,89 մլն
No. of employees
2 հզր
Open
165,44 R$
High
165,44 R$
Low
165,44 R$
Mkt. cap
50,06 մլրդ
Avg. vol.
59,00
Volume
8,00
52-wk high
213,15 R$
52-wk low
143,22 R$
Shares outstanding
62,89 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
Zacks Investment Research
·
12 ժամ առաջ
argenx Meets Primary Endpoint in Phase II Celiac Disease Study
Investing.com
·
17 ժամ առաջ
H.C. Wainwright reiterates argenx stock buy rating on celiac drug data
Yahoo Finance
·
1 օր առաջ
argenx SE (ARGX) Stock Forecasts
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr